[DOI] [PMC free article] [PubMed] [Google Scholar] [48].Yin Z, Ivanov V, Habelhah H, Tew KD, Ronai Z
Nanotechnology-based approaches, including pH-responsive nanoparticles (Yu et al., 2024), biomimetic nanocarriers (Yu et al., 2024), and antibody-drug conjugates (Wang et al., 2024), have been developed to improve the balance between efficacy and toxicity by increasing drug accumulation at tumor sites up to 2.7-fold and reducing systemic exposure
This review does not provide an exhaustive, comprehensive review of the literature
Clinical Ophthalmology, 10 , 18991903
Clinical, Cosmetic and Investigational Dermatology, Volume 15, pp.18531862
Antioxidants as treatment for neurodegenerative disorders